PharmaDrug Appoints World-Renowned DMT Expert Dr. Steven A. Barker to Its Scientific Advisory Board for Psychedelic Pharmaceuticals Post published:February 8, 2021 Post category:Press Release
Bright Minds Biosciences Announces Listing on Canadian Stock Exchange Post published:February 5, 2021 Post category:Press Release
Mindset Files Multiple Final Patent Applications on Its Novel Psilocybin-Inspired Compounds Post published:February 5, 2021 Post category:Press Release
Silo Wellness Closes $2.5 Million Subscription Receipt Financing With Another $2.4 Million in Escrow Post published:February 5, 2021 Post category:Press Release
Tryp Therapeutics Announces Strategic Investment of $2,000,000 Post published:February 5, 2021 Post category:Press Release
Diamond Therapeutics Signs Agreement with McGill University for Research on Low-Dose LSD Post published:February 4, 2021 Post category:Press Release
Cybin Announces Closing of Upsized Bought Deal Offering Post published:February 4, 2021 Post category:Press Release
Psychedelic Bulletin: the Changing Psychedelic Research Landscape; Compass Publishes Therapist Training Programme; and more… Post published:February 4, 2021 Post category:Psychedelic Bulletin
PharmaDrug Signs Supply Agreement with Global Cannabis Supplier and Provides Update on German Operations and Balance Sheet Improvements Post published:February 4, 2021 Post category:Press Release